Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00397800
Recruitment Status : Unknown
Verified August 2012 by Technische Universität München.
Recruitment status was:  Active, not recruiting
First Posted : November 10, 2006
Last Update Posted : August 28, 2012
Sponsor:
Information provided by (Responsible Party):
Technische Universität München

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Actual Primary Completion Date : May 2008
Estimated Study Completion Date : May 2013